Profil bibliographique

Don Yee

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

128Publications signalées

1085Citations signalées

2Affiliations récentes

Les institutions déclarées

University of Minnesota University of Minnesota Medical Center

Les domaines associés

Prostate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesProstate Cancer Treatment and ResearchLung Cancer Research StudiesLung Cancer Diagnosis and Treatment

Les publications récentes

Accès ouvert 2026 article OpenAlex

Stereotactic Versus Conventional Radiotherapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer: A Bayesian Reanalysis of the LUSTRE Randomized Trial

Yanchen Wang, E. Donovan, Mark N. Levine, Timothy J. Whelan et autres

ca (code pays fourni par la source)

0 citations Clinical Lung Cancer

2026 conference-abstract OpenAlex

Abstract PD11-03: Predicting treatment outcomes in breast cancer from H&E slides using pathology foundation models with multiple instance learning

Anthony M. Sun, Sara J. Venters, C. Yau, D. M. Wolf et autres

us, nl (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract PD6-09: Quantifying the Contribution of Doxorubicin and Cyclophosphamide (AC) to Pathologic Response Following Neoadjuvant Taxane Therapy: Analysis of the I-SPY2 TRIAL

Don Yee, C. Yau, P. Norwood, D. M. Wolf et autres

us (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract RF1-04: Early Adverse Symptoms Predict Response to Treatment Among Patients in the I-SPY Trial

A. Basu, S. Umashankar, C. Yau, K. J. Ruddy et autres

us (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract PD10-02: I- SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant vepdegestrant monotherapy or in combination with letrozole or abemaciclib in molecularly selected patients with stage 2/3 HR+ HER2-negative breast cancer (BC)

J. Chien, R. M. Mukhtar, C. Yau, A. D. Elias et autres

us, nl (code pays fourni par la source)

1 citation Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract RF5-06: Pathologic complete response rates (pCR) after the novel HER2 ADC ARX788: Results from the I-SPY2.2 trial

P. R. Pohlmann, H. S. Rugo, C. Yau, Don Yee et autres

us (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract PS1-01-05: Pneumonitis but not other immune related adverse events (irAEs) associate with pre-treatment immune signatures in early-stage breast cancer patients receiving neoadjuvant immunotherapy (IO): results from 5 IO arms in I-SPY2

D. M. Wolf, H. S. Rugo, R. Nanda, S. Umashankar et autres

us (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 article OpenAlex

PS4-05-28: Impact of Neoadjuvant Endocrine Therapy on MammaPrint Index in Hormone Receptor-Positive, HER2-Negative MammaPrint Low Risk Early-Stage Breast Cancer

Saya Jacob, C. Wu, Annuska M. Glas, C. Yau et autres

us (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract PS5-01-24: Evorpacept (ALX-148) combined with trastuzumab deruxtecan in patients with HER2 positive/HER2low metastatic breast cancer (mBC): results from the PRE-ISPY phase Ib trial

P. R. Pohlmann, N. Chen, J. A. Mouabbi, N. Jahan et autres

us, se (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract PS4-02-01: Differential early response to neoadjuvant endocrine therapy in lobular versus non-lobular breast cancer on the Endocrine Optimization Pilot (EOP) of the I-SPY2 Trial

R. Mukhtar, P. Norwood, A. Borowsky, S. Alkhafaji et autres

us (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract PD13-01: Site(s) of Distant Recurrence after Neoadjuvant Therapy for Patients With High-Risk Early-Stage Breast Cancer (BC): Analysis of Data from the I-SPY2 Trial

L. A. Huppert, C. Yau, D. Idossa, Adriana Kahn et autres

us (code pays fourni par la source)

0 citations Clinical Cancer Research

2026 conference-abstract OpenAlex

Abstract PS4-09-08: Expanding Diversity through Innovation: Development of the I-SPY ACCESS Initiative for the I-SPY2.2 and DCIS RECAST Clinical Trials

S. L. Horton, D. A. Idossa, K. C. Hewitt, Jane Perlmutter et autres

us (code pays fourni par la source)

0 citations Clinical Cancer Research

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.